BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10297946)

  • 21. Capitation reimbursement for pharmacy services: a dissenting view.
    Gosselin RA
    Med Mark Media; 1980 Oct; 15(10):51-6. PubMed ID: 10249122
    [No Abstract]   [Full Text] [Related]  

  • 22. Reimbursement for nondispensing functions: today's innovation is tomorrow's tradition.
    Miller JW
    Contemp Pharm Pract; 1979; 2(2):95-8. PubMed ID: 10297463
    [No Abstract]   [Full Text] [Related]  

  • 23. Capitation reimbursement for pediatric primary care.
    Gordon T; DeAngelis C; Peterson R
    Pediatrics; 1986 Jan; 77(1):29-34. PubMed ID: 3510018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medicaid: Medicaid: provider reimbursement--2005. End of Year Issue Brief.
    Johnson P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-11. PubMed ID: 16710912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The life and death of a field experiment: a case study of health care research in a hostile environment.
    Yesalis CE; Levitz GS
    J Health Polit Policy Law; 1985; 9(4):611-28. PubMed ID: 3882819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships among prescription payment methods and interactions between community pharmacists and prescribers.
    Raisch DW
    Ann Pharmacother; 1992; 26(7-8):902-6. PubMed ID: 1504395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior.
    Herbert KE; Urmie JM; Newland BA; Farris KB
    Res Social Adm Pharm; 2006 Sep; 2(3):299-314. PubMed ID: 17138516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacists' views on Indigenous health: is there more that can be done?
    Stoneman J; Taylor SJ
    Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicaid capitation rates: methodological shortcomings and recommended solutions.
    Segodnia WP
    GHAA J; 1988; 9(2):83-95. PubMed ID: 10303216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
    Nutescu EA; Klotz RS
    Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicaid managed care reimbursement for HIV and its implications for access to care.
    Conviser R; Murray M; Lau D
    Am J Manag Care; 2000 Sep; 6(9):990-9. PubMed ID: 11184069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Penny-wise ... pound-foolish? Caps on Medicaid drug payments offset by increased admissions to nursing homes.
    Am J Hosp Pharm; 1992 Feb; 49(2):256. PubMed ID: 1553990
    [No Abstract]   [Full Text] [Related]  

  • 33. Continuing effects of Medicare Part D on rural independent pharmacies who are the sole retail provider in their community.
    Radford A; Mason M; Richardson I; Rutledge S; Poley S; Mueller K; Slifkin R
    Res Social Adm Pharm; 2009 Mar; 5(1):17-30. PubMed ID: 19285286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of a pharmacy benefit to a managed Medicaid population.
    Smith WW; Perry SC
    Med Interface; 1995 Dec; 8(12):84-7, 97. PubMed ID: 10153524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees.
    Murphy AL; MacKinnon NJ; Flanagan PS; Bowles SK; Sketris IS
    Ann Pharmacother; 2005 Apr; 39(4):655-61. PubMed ID: 15728330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Generic substitution' in New Jersey, 1979-87.
    Culkin TT; Mendell S
    Am Pharm; 1989 Feb; NS29(2):25-30. PubMed ID: 2648782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacists' reactions to the Wisconsin Medicaid drug-use review program.
    Brown CM; Lipowski EE
    Am J Hosp Pharm; 1993 Sep; 50(9):1898-902. PubMed ID: 7907839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reimbursement of drug cost-medical assistance program.
    Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
    [No Abstract]   [Full Text] [Related]  

  • 39. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medicaid program; time limitation on price recalculations and recordkeeping requirements under the drug rebate program. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Aug; 68(168):51912-7. PubMed ID: 12962118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.